Evidence map›Paper›PMID 36477758›Full record

ArticlePharmaceutical research2023

Retraction Note: Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.

Armin Mahmoud Salehi, Kheshti, Farnaz Hajizadeh, Asal Barshidi, Bentolhoda Rashidi, Farbod Ebrahimi, Simin Bahmanpour, Vahid Karpisheh, Fatemeh Karimian Noukabadi, Fariba Karoon Kiani and 10 more

RetractedOpen access · bronzeAbstract readRetraction Notice
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 3 countries.

Armin Mahmoud SalehiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
KheshtiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Farnaz HajizadehStudent Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Asal BarshidiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Bentolhoda RashidiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Farbod EbrahimiNanoparticle Process Technology, Faculty of Engineering, University of Duisburg-Essen, Duisburg, Germany.
Simin BahmanpourImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Vahid KarpishehImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Fatemeh Karimian NoukabadiDepartment of Biotechnology, Falavarjan Branch, Islamic Azad University, Isfahan, Iran.
Fariba Karoon KianiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Hadi HassanniaImmunogenetic Research Center, Faculty of Medicine and Amol Faculty of Paramedical Sciences, Mazandaran University of Medical Sciences, Sari, Iran.
Fatemeh AtyabiNanotechnology Research Centre, Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Seyed Hossein KiaieImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Fatah KashanchiLaboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, USA.
Jamshid Gholizadeh NavashenaqNoncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran.
Hamed MohammadiNon-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Rafieh BagherifarNano Drug Delivery Research Center, Kermanshah University of Medical Sciences, Kermanshah, 6715847141, Iran.
Reza JafariNephrology and Kidney Transplant Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran.
Naime Majidi ZolbaninHematology, Immune Cell Therapy, and Stem Cell Transplantation Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran. majidiz.n@umsu.ac.ir.
Farhad Jadidi-NiaraghImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID http://orcid.org/0000-0002-4641-882X
Tabriz University of Medical Sciences · IRUrmia University · IRBam University of Medical Sciences · IRGeorge Mason University · USIslamic Azad University, Isfahan · IRJahrom University of Medical Sciences · IRKermanshah University of Medical Sciences · IRMazandaran University of Medical Sciences · IRTehran University of Medical Sciences · IRUniversity of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36477758
OpenAlexW4310942503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.